P
Peter Schenk
Researcher at Medical University of Vienna
Publications - 89
Citations - 3697
Peter Schenk is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Intensive care & Pulmonary hypertension. The author has an hindex of 34, co-authored 85 publications receiving 3455 citations. Previous affiliations of Peter Schenk include University of Vienna.
Papers
More filters
Journal ArticleDOI
Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis
Peter Schenk,Maximilian Schöniger-Hekele,Valentin Fuhrmann,Christian Madl,Gerd R. Silberhumer,Christian Müller +5 more
TL;DR: The presence of HPS independently worsens prognosis of patients with cirrhosis and should influence patient management and scoring systems and accelerate the evaluation process for liver transplantation.
Journal ArticleDOI
Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences.
TL;DR: Defining arterial hypoxaemia in HPS by different, previously used, cut off values for arterial oxygenation leads to a wide variation in the prevalence of HPS in the same sample of cirrhotic patients.
Journal ArticleDOI
Methylene Blue Improves the Hepatopulmonary Syndrome
TL;DR: It is hypothesized that inhibition of NO-induced vasodilation by methylene blue would improve gas exchange and hemodynamic abnormalities in patients with severe hepatopulmonary syndrome.
Journal ArticleDOI
Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients
Valentin Fuhrmann,Nikolaus Kneidinger,Harald Herkner,Gottfried Heinz,Mariam Nikfardjam,Anja Bojic,Peter Schellongowski,Bernhard Angermayr,Reinhard Kitzberger,Joanna Warszawska,Ulrike Holzinger,Peter Schenk,C Madl +12 more
TL;DR: Hypoxic hepatitis is the consequence of multiorgan injury and outcome is influenced by the severity of liver impairment and the etiology and severity of the basic disease.
Journal ArticleDOI
Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD
K Vonbank,R Ziesche,T W Higenbottam,Leopold Stiebellehner,Ventzislav Petkov,Peter Schenk,Peter Germann,Lutz-Henning Block +7 more
TL;DR: This is the first controlled trial indicating that the “pulsed” inhalation of nitric oxide together with oxygen may be safely and effectively used for the long term treatment of severe COPD.